These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9288090)

  • 1. What is expanded in progressive myoclonus epilepsy?
    Lalioti MD; Scott HS; Antonarakis SE
    Nat Genet; 1997 Sep; 17(1):17. PubMed ID: 9288090
    [No Abstract]   [Full Text] [Related]  

  • 2. Unstable insertion in the 5' flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1.
    Lafrenière RG; Rochefort DL; Chrétien N; Rommens JM; Cochius JI; Kälviäinen R; Nousiainen U; Patry G; Farrell K; Söderfeldt B; Federico A; Hale BR; Cossio OH; Sørensen T; Pouliot MA; Kmiec T; Uldall P; Janszky J; Pranzatelli MR; Andermann F; Andermann E; Rouleau GA
    Nat Genet; 1997 Mar; 15(3):298-302. PubMed ID: 9054946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy.
    Lalioti MD; Scott HS; Buresi C; Rossier C; Bottani A; Morris MA; Malafosse A; Antonarakis SE
    Nature; 1997 Apr; 386(6627):847-51. PubMed ID: 9126745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epilepsy. Protease inhibitor implicated.
    McNamara JO; Puranam RS
    Nature; 1996 May; 381(6577):26-7. PubMed ID: 8609982
    [No Abstract]   [Full Text] [Related]  

  • 5. Allelic heterogeneity of Mediterranean myoclonus and the cystatin B gene.
    Labauge P; Ouazzani R; M'Rabet A; Grid D; Genton P; Dravet C; Chkili T; Beck C; Buresi C; Baldy-Moulinier M; Malafosse A
    Ann Neurol; 1997 May; 41(5):686-9. PubMed ID: 9153533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene perplexes epilepsy researchers.
    O'Brien C
    Science; 1996 Mar; 271(5256):1672. PubMed ID: 8596927
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1).
    Pennacchio LA; Lehesjoki AE; Stone NE; Willour VL; Virtaneva K; Miao J; D'Amato E; Ramirez L; Faham M; Koskiniemi M; Warrington JA; Norio R; de la Chapelle A; Cox DR; Myers RM
    Science; 1996 Mar; 271(5256):1731-4. PubMed ID: 8596935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From gene to disease; progressive myoclonus epilepsy of Unverricht-Lundborg and mutations in the cystatin B gene].
    de Haan GJ; Halley DJ; Deelen WH; Lindhout D
    Ned Tijdschr Geneeskd; 2002 May; 146(18):846-8. PubMed ID: 12038222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1).
    Lalioti MD; Mirotsou M; Buresi C; Peitsch MC; Rossier C; Ouazzani R; Baldy-Moulinier M; Bottani A; Malafosse A; Antonarakis SE
    Am J Hum Genet; 1997 Feb; 60(2):342-51. PubMed ID: 9012407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human genetics. Breaking the rule of three.
    Mandel JL
    Nature; 1997 Apr; 386(6627):767-9. PubMed ID: 9126731
    [No Abstract]   [Full Text] [Related]  

  • 11. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice.
    Pennacchio LA; Bouley DM; Higgins KM; Scott MP; Noebels JL; Myers RM
    Nat Genet; 1998 Nov; 20(3):251-8. PubMed ID: 9806543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of the mouse cystatin B gene.
    Pennacchio LA; Myers RM
    Genome Res; 1996 Nov; 6(11):1103-9. PubMed ID: 8938434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the QVVAG region of the cysteine proteinase inhibitor stefin B.
    Jerala R; Trstenjak-Prebanda M; Kroon-Zitko L; Lenarcic B; Turk V
    Biol Chem Hoppe Seyler; 1990 May; 371 Suppl():157-60. PubMed ID: 2400576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive myoclonus epilepsy of Unverricht-Lundborg type.
    Lehesjoki AE; Koskiniemi M
    Epilepsia; 1999; 40 Suppl 3():23-8. PubMed ID: 10446747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel cystatin B mutation and diagnostic PCR assay in an Unverricht-Lundborg progressive myoclonus epilepsy patient.
    Bespalova IN; Adkins S; Pranzatelli M; Burmeister M
    Am J Med Genet; 1997 Sep; 74(5):467-71. PubMed ID: 9342192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epilepsy, the protease inhibitor and the dodecamer: progressive myoclonus epilepsy, cystatin b and a 12-mer repeat expansion.
    Lalioti MD; Antonarakis SE; Scott HS
    Cytogenet Genome Res; 2003; 100(1-4):213-23. PubMed ID: 14526183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystatins as calpain inhibitors: engineered chicken cystatin- and stefin B-kininogen domain 2 hybrids support a cystatin-like mode of interaction with the catalytic subunit of mu-calpain.
    Díaz BG; Gross S; Assfalg-Machleidt I; Pfeiler D; Gollmitzer N; Gabrijelcic-Geiger D; Stubbs MT; Fritz H; Auerswald EA; Machleidt W
    Biol Chem; 2001 Jan; 382(1):97-107. PubMed ID: 11258679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The minisatellite expansion mutation in EPM1: resolution of an initial discrepancy. Mutatations in brief no. 186. Online.
    Virtaneva K; Paulin L; Krahe R; de la Chapelle A; Lehesjoki AE
    Hum Mutat; 1998; 12(3):218. PubMed ID: 10660338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1.
    Virtaneva K; D'Amato E; Miao J; Koskiniemi M; Norio R; Avanzini G; Franceschetti S; Michelucci R; Tassinari CA; Omer S; Pennacchio LA; Myers RM; Dieguez-Lucena JL; Krahe R; de la Chapelle A; Lehesjoki AE
    Nat Genet; 1997 Apr; 15(4):393-6. PubMed ID: 9090386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular background of progressive myoclonus epilepsy.
    Lehesjoki AE
    EMBO J; 2003 Jul; 22(14):3473-8. PubMed ID: 12853462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.